Antibody Drug Conjugate Market is Anticipating to Increase at a Substantial CAGR of 19% During Forecast to 2023


Antibody Drug Conjugate Market Analysis:

Various factors are adding to the global antibody drug conjugate market share. These factors, as per the new MRFR report, include advances in medical technology, rising cases of cancer, growing obese population, and increasing aging population. Additional factors adding market growth include increasing collaborations between biotechnology companies, biopharmaceuticals, and research institutes, rising R&D on oncology diseases, increasing research on advanced drug discoveries, rising number of research on antibody therapies, and preclinical research. 
The global Antibody Drug Conjugate Market Growth likely to grow at a 19% CAGR between 2017- 2023, reveals the new Market Research Future (MRFR) report. Antibody drug conjugates are new-age therapeutic agents that have three parts- a chemical linker to attach cytotoxic agents to antibodies, cytotoxic agents for killing target cancer cells, and specific antibodies for binding. Lymphoma, multiple myeloma, breast cancer, solid tumors, skin cancer, ovary cancer, colon cancer, lung cancer, glioblastoma, pancreas cancer, kidney cancer, prostate cancer, leukemia, and others are some of its key applications. The different antibody drug conjugates include drug/toxin, linker, and monoclonal antibodies, to name a few. 


On the contrary, shortage of funds & high procedure prices are factors that are likely to impede the global antibody drug conjugate market growth during the forecast period.

Competitive Analysis:

Vaccinex Inc (U.S.), Antikor (U.K), Agensys, Inc. (U.S.), Concortis Biotherapeutics (U.S.), Genentech (U.S.), Roche Holding AG (Switzerland), ImmunoGen, Inc.(U.S.), and Seattle Genetics (U.S.)

Market Segmentation:

·         The MRFR report provides an inclusive segmental analysis of the antibody drug conjugate market by end user, application, technology, product, and type. 

·         Based on type, the antibody drug conjugate market has been segmented into drug/toxin, linker, monoclonal antibodies, & other types. 

·         Based on application, the market for antibody drug conjugate has been segmented into solid tumors, skin, lymphoma, multiple myeloma, cancer, colon cancer, lung cancer, glioblastoma, ovary cancer, pancreas cancer, kidney cancer, prostate cancer, leukemia, and others.

·         By product, the antibody drug conjugate market has been segmented into adcertis, kadcyla, & other products. 

·         By technology, the global antibody drug conjugate market has been segmented into ImmunoGen technology, immunomedics technology, Seattle genetics technology, and others. 

·         By end user, the antibody drug conjugate market is segmented into biopharmaceutical companies, biotechnology companies, academic research institutes, specialized cancer centers, hospitals, and others. 

Regional Analysis:

Based on the region, the global antibody drug conjugate market covers the recent trends and growth opportunities across Europe, the Asia Pacific (APAC), the Americas, and the Middle East and Africa (MEA). Of these, the Americas will have the lions share in the market over the forecast period for increasing healthcare awareness and rising prevalence of cancer. 

The antibody drug conjugate market in Europe is predicted to have healthy growth over the forecast period for the huge population being affected by cancer. Besides, the government is focussing on R&D to develop new drugs to offer citizens the best treatment. 


The antibody drug conjugate market in the APAC region is predicted to grow at a fast rate over the forecast period due to increasing prevalence of cancer in India & China. 

The antibody drug conjugate market in the MEA is predicted to have steady growth over the forecast period. 

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Comments

Post a Comment

Popular posts from this blog

Gene Therapy Market Mobilizing Viral Vector Manufacturing Market

Market Overview: The global viral vector manufacturing market is expected to exhibit a strong 22.65% CAGR over the forecast period from 2018 to 2023 , according to the latest research report from Market Research Future (MRFR). The report forecasts a valuation of USD 319 million for the market by the end of the 2018-2023 forecast period. In current time, gene therapy is one of the preferred treatment options for most chronic diseases, that involves the insertion of a functional copy of a gene into a defective cell. viral vectors and the absence of the appropriate tools are likely to be the key restraints acting against the global Viral Vector Manufacturing Market Size over the forecast period. Many companies in the global viral vector manufacturing market are taking steps to counter the difficulties in producing viral vectors and this area is likely to remain a hive of activity in the coming years. This has also resulted in strong growth prospects for companies that can develop e...
Read more

Negative Pressure Wound Therapy Market is Increasing at a Healthy CAGR of 6.7% During Forecast to 2023

    MRFR Processed new research on “Negative Pressure Wound Therapy Market-Global Forecast to   Market Analysis:    The worldwide negative pressure wound therapy market is predicted to grow at a 6.7% CAGR during the forecast period (2018-2023), according to the latest Market Research Future (MRFR) report. Negative pressure wound therapy or NPWT, which is also called vacuum-assisted wound closure, includes the use of sub-atmospheric pressure for healing chronic and acute wounds. These devices come in assorted sizes and shapes to match the patient’s body contour and also the wound size to be treated. NPWT devices have a dressing set, drainage tubing, and vacuum pump that along with promoting wound healing also helps in reducing recurrent usage of dressings, offer an effective choice for managing closed surgical incision lines as well as augment the well-being of the patient.    Also Read: https://www.medgadget.com/2020/02/negative-pressur...
Read more

North Americas Uplifting 3D Printed Medical Implants Market

Market Overview: Expanding innovative advances in 3D printed implants, for example, improvement of CT-Bone, bone indistinguishable redid embed for use in mandible and zygoma increase procedure should help business development. Its controlled porosity empowers it to fit life structures of the patient, in this manner, dominatingly driving industry development. Also, increment in medicinal services consumption, ascend in R&D venture, flood in number of medical procedures and expanding extent of 3D innovation in biomedical application will spike income size during the figure time frame. In any case, factors, for example, significant expense of printers, longer creation courses of events, absence of talented representatives and absence of in-house added substance fabricating assets is relied upon to obstruct 3D printed implants market development over the coming years. The market for 3D Printed Medical Implants Market   is likely to register a CAGR of 18.1% during the foreca...
Read more